GlucotrackGCTK
13F holders, Q4 2025 (December 31)10holders +2
2new positions
0sold out
$3.87avg. 13F price*
At the end of Q4 2025, 10 institutions reported holding Glucotrack Inc. (GCTK) in their 13F filings, up 2 from Q3 2025. 2 opened new positions and 0 sold out. The largest holders were Ikarian Capital, LLC ($177K), Boothbay Fund Management, LLC ($52K) and Alerus Financial NA ($15K).
- Company
- Glucotrack Inc.
- CUSIP
- 45824Q804
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $230K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 59,455 shares bought and 1,781 shares sold, net +57,674 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Ikarian Capital, LLC | 0.02% | New | 45,830 | $177K |
| Boothbay Fund Management, LLC | 0.00% | New | 13,525 | $52K |
| Alerus Financial NA | 0.00% | Reduce -20.0% | 4,000 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -47.3% | 425 | $2K |
| UBS Group AG | 0.00% | Add +197.5% | 119 | $461 |
| NFSG Corp | 0.00% | No change | 34 | $132 |
| Bank of America Corp. | 0.00% | Add +300.0% | 28 | $108 |
| SBI Securities Co., Ltd. | 0.00% | No change | 9 | $35 |
| Morgan Stanley | 0.00% | Reduce -99.8% | 1 | $4 |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is GCTK's weight in each manager's 13F, not the share of Glucotrack Inc. the manager owns.